Treatment of helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

Scandinavian Journal of Gastroenterology

Volumn 28, Issue 11, 1993, Pages 939-942

  Graham, D Y ^a   Hepps, K S ^a   Ramirez, F C ^a   Lew, G M ^a   Saeed, Z A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antimicrobial therapy; Bismuth subsalicylate; Clinical trial; Duodenal ulcer; Gastric ulcer; Helicobacter pylori; Maintenance; Ranitidine; Ulcer recurrence

Indexed keywords

BISMUTH CITRATE; BISMUTH SALICYLATE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; RANITIDINE; TETRACYCLINE;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT PEPTIC ULCER; STOMACH ULCER;

ADULT; AGED; BISMUTH; COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MALE; METRONIDAZOLE; MIDDLE AGE; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER; PROSPECTIVE STUDIES; RANITIDINE; RECURRENCE; SALICYLATES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TETRACYCLINE;

EID: 0027495920     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529309098288     Document Type: Article

References (24)

1. Campylobacter pylori and peptic ulcer disease
2. Effect of treatment of Helicobacter pylori on the recurrence of gastric ulcers or duodenal ulcers: a randomized controlled study
3. Campylobacter pylori and recurrence of duodenal ulcers-a 12-month follow-up study
4. Effect of colloidal bismuth (De-Nol) on healing and relapse of duodenal ulcers-role of Campylobacter pyloridis
5. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori
6. Cure of duodenal ulcer associated with eradication of Helicobacter pylori
7. Cure of duodenal ulcer after eradication of Helicobacter pylori
8. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing with ranitidine: a randomized controlled trial
9. A comparison of ranitidine and tripotassium dicitrato-bismuth (T.D.B.) in relapse rates of duodenal ulcer. The role of Campylobacter pylori (C.P.)
10. Late results of medical and surgical treatment of bleeding peptic ulcer
11. Campylobacter pylori detected noninvasively by the 13C-urea breath test
12. A sensitive and specific serologic test for detection of Campylobacter pylori infection
13. Factors influencing the eradication of Helicobacter pylori with triple therapy
14. The late results of medical and surgical treatment for bleeding duodenal ulcer
15. A retrospective study on the outcome of massive bleeding from peptic ulceration
16. Late outcome of bleeding gastric ulcers
17. Bleeding duodenal ulcer: reduction in mortality with a planned approach
18. Efficacy and safety of long-term maintenance therapy of duodenal ulcers
19. Long-term follow-up of duodenal ulcer patients
20. Long-term management of patients with bleeding ulcers. Rationale, results, and economic impact
21. Current status of maintenance therapy in peptic ulcer disease
22. Long-term recurrence of peptic ulceration and rebleeding with H2 maintenance, surgery, or no maintenance therapy
23. Randomized controlled study of ranitidine maintenance for patients with a recent severe duodenal ulcer hemorrhage
24. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer